Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for P48651

Entry ID Method Resolution Chain Position Source
AF-P48651-F1 Predicted AlphaFoldDB

291 variants for P48651

Variant ID(s) Position Change Description Diseaes Association Provenance
rs149279242
RCV002537584
CA4816507
RCV000905296
72 G>S Inborn genetic diseases [ClinVar] Yes ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1810593860
RCV001196358
83 I>L Lenz-Majewski hyperostosis syndrome [ClinVar] Yes ClinVar
dbSNP
CA371754196
rs1131691429
RCV000493041
RCV001253177
95 R>Q Lenz-Majewski hyperostosis syndrome [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA371754319
RCV001252718
rs1275425796
112 F>V Microcephaly [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
VAR_070987
CA149739
RCV000083282
rs587777090
265 L>P Lenz-Majewski hyperostosis syndrome LMHD; does not affect protein levels; increases the rate of phosphatidylserine synthesis; profoundly impairs negative feedback enzyme regulation by phosphatidylserine [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
RCV000083281
VAR_070988
CA149738
rs587777089
269 P>S Lenz-Majewski hyperostosis syndrome LMHD; does not affect protein levels; increases the rate of phosphatidylserine synthesis; profoundly impairs negative feedback enzyme regulation by phosphatidylserine [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
rs1811091915
RCV001328789
283 S>F Lenz-Majewski hyperostosis syndrome [ClinVar] Yes ClinVar
dbSNP
CA371757379
rs1586200380
RCV000984910
311 F>C Lenz-Majewski hyperostosis syndrome [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
CA371757431
RCV000988099
rs1586200389
318 P>L Lenz-Majewski hyperostosis syndrome [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
rs587777088
RCV000083280
CA149737
VAR_070989
353 Q>R Lenz-Majewski hyperostosis syndrome LMHD; does not affect protein levels; increases the rate of phosphatidylserine synthesis; profoundly impairs negative feedback enzyme regulation by phosphatidylserine [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
Ensembl
dbSNP
CA371752318
rs1373990657
2 A>E No ClinGen
gnomAD
rs748205802
CA4816456
3 S>F No ClinGen
ExAC
TOPMed
gnomAD
rs11545844
CA181490581
4 C>S No ClinGen
Ensembl
CA371752350
rs1172182497
5 V>M No ClinGen
gnomAD
CA371752367
rs1394655724
6 G>E No ClinGen
gnomAD
rs769720914
CA4816457
8 R>Q No ClinGen
ExAC
gnomAD
CA371752392
rs1435608646
8 R>W No ClinGen
TOPMed
gnomAD
rs772997528
CA4816458
9 T>A No ClinGen
ExAC
gnomAD
CA4816459
rs772997528
9 T>P No ClinGen
ExAC
gnomAD
rs144822699
CA4816460
14 D>N No ClinGen
ESP
ExAC
gnomAD
CA371752479
rs1326957547
15 V>A No ClinGen
gnomAD
rs1436473798
CA371752492
16 N>S No ClinGen
TOPMed
CA371752506
rs1436935923
17 Y>C No ClinGen
gnomAD
rs759201091
CA4816462
18 K>R No ClinGen
ExAC
gnomAD
rs767313221
CA4816463
19 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs1563555915
CA371752551
20 H>R No ClinGen
Ensembl
rs760082933
CA4816465
23 M>I No ClinGen
ExAC
gnomAD
CA371752590
rs1348007073
23 M>V No ClinGen
gnomAD
TCGA novel 24 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371752624
rs1262976573
25 N>D No ClinGen
gnomAD
rs763702650
CA181490600
26 E>K No ClinGen
ExAC
TOPMed
gnomAD
CA4816466
rs763702650
26 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1586177025
CA371752689
29 V>G No ClinGen
Ensembl
CA371752728
rs1180208517
32 I>V No ClinGen
TOPMed
CA371752743
rs751925742
33 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA4816470
rs751925742
33 T>S No ClinGen
ExAC
TOPMed
gnomAD
rs1281123923
CA371752783
36 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs755150411
CA4816471
38 Y>S No ClinGen
ExAC
TOPMed
gnomAD
CA4816473
rs748448029
39 R>Q No ClinGen
ExAC
gnomAD
CA371752874
rs1370053835
43 I>V No ClinGen
gnomAD
TCGA novel 46 L>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 49 T>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1441176979
CA371752969
50 I>T No ClinGen
gnomAD
rs1240153836
CA371752964
50 I>V No ClinGen
TOPMed
rs771000792
CA4816477
54 M>R No ClinGen
ExAC
gnomAD
CA4816478
rs138669657
55 Y>F No ClinGen
ESP
ExAC
gnomAD
CA371753054
rs1393929603
57 A>D No ClinGen
TOPMed
CA371753051
rs1212419473
57 A>T No ClinGen
TOPMed
gnomAD
CA181495083
rs770990297
63 S>F No ClinGen
Ensembl
CA371753120
rs1293872968
65 P>S No ClinGen
TOPMed
rs1586182327
CA371753146
68 N>K No ClinGen
Ensembl
CA371753149
rs1412317073
69 I>V No ClinGen
gnomAD
rs548182662
CA4816506
71 R>K No ClinGen
1000Genomes
ExAC
gnomAD
rs1356614934
CA371753169
71 R>S No ClinGen
gnomAD
rs112204704
CA181495088
73 I>V No ClinGen
Ensembl
CA4816508
rs767755619
74 L>F No ClinGen
ExAC
gnomAD
rs200857021
CA4816510
75 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs200857021
CA4816509
75 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA371753194
rs1228621341
76 V>A No ClinGen
gnomAD
rs1586182367
CA371753200
77 I>T No ClinGen
Ensembl
CA371753209
rs1251071007
78 F>L No ClinGen
gnomAD
CA371753244
rs1276967878
83 I>T No ClinGen
gnomAD
CA371753252
rs1453664601
84 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs536953263
CA4816511
88 F>L No ClinGen
1000Genomes
ExAC
gnomAD
rs1258371359
CA371753291
90 N>S No ClinGen
gnomAD
CA181500047
rs759816359
92 P>L No ClinGen
Ensembl
TCGA novel 94 T>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs367964462
CA4816534
102 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371754259
rs1327643828
104 V>G No ClinGen
gnomAD
TCGA novel 105 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs934383157
CA181501171
110 L>F No ClinGen
Ensembl
rs751508988
CA4816554
111 Y>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 116 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371754350
rs1462593441
117 F>I No ClinGen
TOPMed
CA181501178
rs1054151156
120 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs767237143
CA4816556
122 N>S No ClinGen
ExAC
gnomAD
CA4816558
RCV000906739
rs536174142
123 F>L No ClinGen
ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
CA4816559
rs777384907
124 E>K No ClinGen
ExAC
gnomAD
TCGA novel 125 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4816560
rs748935593
125 Q>E No ClinGen
ExAC
gnomAD
rs1195907821
CA371754408
125 Q>H No ClinGen
TOPMed
CA371754410
rs1369272542
126 V>L No ClinGen
gnomAD
rs370004918
CA4816562
129 L>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1183729827
CA371754443
131 Y>H No ClinGen
gnomAD
CA371754464
rs1416260117
134 D>N No ClinGen
gnomAD
RCV001089765
rs1810833573
137 L>F No ClinVar
dbSNP
CA181501212
rs1039312152
138 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4816563
rs747493340
138 R>P No ClinGen
ExAC
gnomAD
rs747493340
CA371754493
138 R>Q No ClinGen
ExAC
gnomAD
rs769835679
CA4816565
140 A>T No ClinGen
ExAC
gnomAD
RCV000443001
rs1057521718
CA16606178
141 T>A No ClinGen
ClinVar
Ensembl
dbSNP
rs748543683
CA4816566
141 T>K No ClinGen
ExAC
TOPMed
gnomAD
rs1057521718
CA371754509
141 T>S No ClinGen
Ensembl
CA4816568
rs773452274
142 R>G No ClinGen
ExAC
gnomAD
CA371754512
rs773452274
142 R>W No ClinGen
ExAC
gnomAD
rs141629731
CA4816569
143 E>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4816570
rs766465340
144 A>V No ClinGen
ExAC
gnomAD
CA4816571
rs774304076
147 M>V No ClinGen
ExAC
gnomAD
CA181504037
rs4565430
148 E>Q No ClinGen
Ensembl
TCGA novel 149 Y>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA181504040
rs1011238847
150 A>T No ClinGen
Ensembl
rs1318816895
CA371754584
151 V>M No ClinGen
TOPMed
rs1249089428
CA371754612
153 C>F No ClinGen
TOPMed
gnomAD
rs1249089428
CA371754610
153 C>Y No ClinGen
TOPMed
gnomAD
rs1451546343
CA371754615
154 H>N No ClinGen
gnomAD
rs201182618
CA4816594
154 H>R No ClinGen
1000Genomes
ExAC
gnomAD
CA4816596
rs753581325
155 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA371754675
rs1404208233
159 E>K No ClinGen
gnomAD
CA371754751
rs1319616236
164 H>D No ClinGen
gnomAD
rs1365732047
CA371754771
165 F>C No ClinGen
gnomAD
TCGA novel 165 F>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1291828630
CA371754786
166 D>G No ClinGen
TOPMed
CA371754803
rs1436822451
167 I>M No ClinGen
TOPMed
gnomAD
rs1395888873
CA371754826
169 A>V No ClinGen
TOPMed
CA4816599
rs750138177
171 G>E No ClinGen
ExAC
gnomAD
rs757948467
CA4816600
174 W>* No ClinGen
ExAC
gnomAD
rs1464399774
CA371754897
174 W>S No ClinGen
TOPMed
rs1233291391
CA371754915
175 G>V No ClinGen
gnomAD
CA371754938
rs1423352389
177 A>S No ClinGen
TOPMed
rs368150019
CA4816601
179 K>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4816602
rs753241269
182 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs202206461
CA371755044
187 G>C No ClinGen
1000Genomes
TOPMed
gnomAD
CA181504058
rs975917322
187 G>D No ClinGen
TOPMed
rs202206461
CA181504052
187 G>S No ClinGen
1000Genomes
TOPMed
gnomAD
CA371755082
rs1434010070
190 W>C No ClinGen
gnomAD
TCGA novel 191 T>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 192 I>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1468522060
CA371755190
199 T>N No ClinGen
gnomAD
CA371755195
rs1348365904
200 E>K No ClinGen
TOPMed
gnomAD
CA371756051
rs1356085783
201 L>P No ClinGen
TOPMed
CA181505253
rs897699454
204 M>L No ClinGen
TOPMed
rs1257318976
CA371756097
204 M>R No ClinGen
gnomAD
rs780067819
CA4816629
205 H>Y No ClinGen
ExAC
gnomAD
TCGA novel 208 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM290392
CA4816630
rs375073869
209 N>S Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4816632
rs776404022
212 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1251782763
CA371756304
219 I>V No ClinGen
TOPMed
TCGA novel 221 D>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs748373115
CA181505262
225 C>* No ClinGen
Ensembl
CA4816637
rs766157225
228 G>S No ClinGen
ExAC
gnomAD
CA371756416
rs1209769402
229 G>S No ClinGen
TOPMed
rs758944053
CA4816639
231 W>R No ClinGen
ExAC
gnomAD
CA4816640
rs767123710
233 G>A No ClinGen
ExAC
gnomAD
CA371756451
rs1180114934
234 M>I No ClinGen
gnomAD
CA4816641
CA4816642
rs754291059
234 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs1586197202
CA371756457
235 V>G No ClinGen
Ensembl
rs368785037
COSM1102772
CA4816644
236 V>I endometrium [Cosmic] No ClinGen
cosmic curated
ESP
ExAC
TOPMed
gnomAD
CA4816646
rs758567950
238 R>L No ClinGen
ExAC
gnomAD
CA4816645
rs758567950
238 R>Q No ClinGen
ExAC
gnomAD
CA181505291
rs964046382
238 R>W No ClinGen
TOPMed
gnomAD
CA371756474
rs1586197224
239 F>V No ClinGen
Ensembl
CA371756503
rs1436258686
242 M>I No ClinGen
gnomAD
rs1586197240
CA371756513
244 T>A No ClinGen
Ensembl
rs1305613002
CA371756515
244 T>N No ClinGen
TOPMed
rs1017730495
CA181505298
246 H>Q No ClinGen
TOPMed
CA371756547
rs1375356638
COSM1222439
248 A>V large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA371756551
rs1380545163
249 S>N No ClinGen
gnomAD
rs538008429
CA4816663
251 K>N No ClinGen
1000Genomes
ExAC
gnomAD
CA4816664
rs763273749
254 H>Y No ClinGen
ExAC
gnomAD
CA371756783
rs1170399535
256 T>S No ClinGen
TOPMed
rs113743527
CA181506383
261 K>T No ClinGen
Ensembl
rs1811090763
RCV001217556
263 A>missing No ClinVar
dbSNP
rs183329073
CA181506388
268 T>A No ClinGen
1000Genomes
CA371756874
rs1436287261
270 A>G No ClinGen
TOPMed
gnomAD
rs1300025822
CA371756890
272 W>* No ClinGen
TOPMed
gnomAD
rs754034904
CA4816667
274 Y>C No ClinGen
ExAC
TOPMed
gnomAD
rs1218683875
CA371756908
275 V>F No ClinGen
gnomAD
CA4816669
rs142695191
COSM170637
276 R>* large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1312675418
CA371756915
276 R>L No ClinGen
gnomAD
rs756063298
TCGA novel
CA4816670
277 W>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
ClinGen
ExAC
TOPMed
gnomAD
rs1464217539
CA371756950
281 K>R No ClinGen
gnomAD
CA371756949
rs1464217539
281 K>T No ClinGen
gnomAD
COSM3432649
rs1249447586
CA371756957
282 S>Y large_intestine Variant assessed as Somatic; 4.62e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
rs1209134147 283 S>missing Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No NCI-TCGA
rs1476854796
CA371756978
285 Q>R No ClinGen
gnomAD
CA4816672
rs749275787
286 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA4816675
rs147937398
287 V>A No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4816674
rs778867009
287 V>I No ClinGen
ExAC
gnomAD
CA4816677
rs139349789
288 A>D No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4816676
rs771791571
288 A>P No ClinGen
ExAC
gnomAD
CA371757032
rs1458053442
294 M>L No ClinGen
TOPMed
gnomAD
CA371757040
rs1323007000
295 I>V No ClinGen
gnomAD
rs1348332195
CA371757058
297 W>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1404978973
CA371757297
300 T>A No ClinGen
gnomAD
TCGA novel 301 E>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371757307
rs1351847405
301 E>V No ClinGen
gnomAD
TCGA novel 303 N>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs762544416
RCV000413772
CA16042746
304 T>N No ClinGen
ClinVar
dbSNP
gnomAD
TCGA novel 304 T>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1586200351
CA371757325
304 T>P No ClinGen
Ensembl
rs757267921
CA4816692
307 L>W No ClinGen
ExAC
TOPMed
gnomAD
CA4816693
rs373266938
309 H>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1290088550
CA371757440
320 S>G No ClinGen
gnomAD
CA371757442
rs1203131518
320 S>N No ClinGen
Ensembl
CA4816696
rs779602012
330 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA4816697
rs746733290
331 T>K No ClinGen
ExAC
rs768143113
CA4816698
334 T>S No ClinGen
ExAC
TCGA novel 337 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 338 Y>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 338 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371757150
rs1188091614
339 Y>C No ClinGen
gnomAD
rs984167973
CA371757178
343 T>I No ClinGen
gnomAD
rs1586201946
CA371757174
343 T>P No ClinGen
Ensembl
rs984167973
CA181491223
343 T>S No ClinGen
gnomAD
CA4816717
COSM1194623
rs747675786
344 D>N lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA371757187
rs1408116620
345 T>A No ClinGen
gnomAD
CA181491239
rs878935975
347 C>R No ClinGen
Ensembl
CA181491243
rs894531875
349 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA4816720
rs746427419
350 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA181491251
rs746427419
350 V>L No ClinGen
ExAC
gnomAD
TCGA novel 358 G>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs769187486
CA4816743
360 I>T No ClinGen
ExAC
gnomAD
rs1201716526
CA371758081
360 I>V No ClinGen
gnomAD
CA371758102
rs1370935616
363 L>V No ClinGen
TOPMed
gnomAD
CA371758117
rs1158118350
365 A>D No ClinGen
gnomAD
rs1181431175
CA371758127
367 V>I No ClinGen
TOPMed
CA4816745
rs755348572
369 I>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 372 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1455019490
CA371758181
374 D>G No ClinGen
gnomAD
rs1010571471
CA181498336
381 I>L No ClinGen
Ensembl
CA4816750
rs751543129
381 I>M No ClinGen
ExAC
TOPMed
gnomAD
rs766245808
CA4816749
381 I>T No ClinGen
ExAC
gnomAD
TCGA novel 382 L>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 383 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4816752
rs767365710
385 V>A No ClinGen
ExAC
gnomAD
rs1563582954
CA371758275
388 L>P No ClinGen
Ensembl
TCGA novel 389 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA181498376
rs200992477
391 V>A No ClinGen
gnomAD
rs781468003
CA181498373
391 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs781468003
CA4816754
391 V>M No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 392 A>= Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 392 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371758306
rs1248520559
392 A>T No ClinGen
gnomAD
CA371758310
rs1272567302
392 A>V No ClinGen
gnomAD
CA4816767
rs771034385
394 T>I No ClinGen
ExAC
gnomAD
rs774267515
CA4816768
396 F>L No ClinGen
ExAC
gnomAD
rs759525618
CA4816769
397 L>R No ClinGen
ExAC
gnomAD
CA4816770
rs575649350
398 C>S No ClinGen
1000Genomes
ExAC
gnomAD
RCV000938578
rs144997851
CA4816771
400 Y>H No ClinGen
ClinVar
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA4816773
rs561447654
401 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA4816774
rs564223313
403 I>M No ClinGen
1000Genomes
ExAC
gnomAD
rs1351892730
CA371758383
404 W>R No ClinGen
TOPMed
CA371758386
rs1166617323
404 W>S No ClinGen
TOPMed
CA181503196
rs916463087
405 Y>C No ClinGen
gnomAD
rs1025716900
CA181503202
406 A>T No ClinGen
TOPMed
gnomAD
CA181503206
rs947991928
407 E>A No ClinGen
Ensembl
COSM3779437
CA181503208
rs1044410031
408 H>R Variant assessed as Somatic; impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
CA4816775
rs756721220
409 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA371758439
rs1295602847
412 R>* No ClinGen
TOPMed
gnomAD
rs1295602847
CA371758438
412 R>G No ClinGen
TOPMed
gnomAD
CA4816777
rs368400477
412 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371758457
COSM1132660
rs1297875969
CA371758456
414 K>N prostate [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA371758454
rs1229192023
414 K>R No ClinGen
gnomAD
CA4816802
rs146784811
417 S>L No ClinGen
ESP
ExAC
gnomAD
CA181503743
rs1053756490
419 C>R No ClinGen
TOPMed
CA4816803
rs184841579
COSM1287446
419 C>Y Variant assessed as Somatic; 0.0 impact. autonomic_ganglia [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA4816804
rs772180656
420 E>K No ClinGen
ExAC
gnomAD
rs141163428
CA4816805
422 G>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371758524
rs1563588044
423 T>A No ClinGen
Ensembl
RCV000953761
CA4816806
rs7835798
VAR_048735
423 T>N No ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA4816809
rs776491858
424 Y>C No ClinGen
ExAC
gnomAD
rs556701669
CA4816808
424 Y>H No ClinGen
1000Genomes
ExAC
gnomAD
rs796677792
CA181503812
426 P>T No ClinGen
Ensembl
RCV000971765
CA4816811
rs201801916
427 E>G No ClinGen
ClinVar
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA4816812
rs773045928
428 I>T No ClinGen
ExAC
gnomAD
CA181503831
rs1035296583
428 I>V No ClinGen
TOPMed
gnomAD
TCGA novel 430 W>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs970889178
CA181503850
431 H>Y No ClinGen
TOPMed
gnomAD
CA4816813
rs762517295
434 K>T No ClinGen
ExAC
gnomAD
TCGA novel 439 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA181505010
rs953693483
443 P>L No ClinGen
TOPMed
rs770288541
CA4816836
444 P>H No ClinGen
ExAC
TOPMed
gnomAD
CA371758891
rs770288541
444 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA4816837
rs773916228
447 A>T No ClinGen
ExAC
TOPMed
gnomAD
CA371758927
rs1586214754
RCV000999059
449 N>S No ClinGen
ClinVar
Ensembl
dbSNP
rs554561031
CA4816839
450 N>H No ClinGen
1000Genomes
ExAC
gnomAD
rs1286686340
CA371758950
452 S>N No ClinGen
TOPMed
CA4816841
rs762160826
453 H>Y No ClinGen
ExAC
gnomAD
rs765649190
CA4816842
455 S>C No ClinGen
ExAC
gnomAD
CA4816844
rs750590433
459 N>T No ClinGen
ExAC
gnomAD
rs758655652
CA4816845
460 R>P No ClinGen
ExAC
gnomAD
rs758655652
CA371759001
460 R>Q No ClinGen
ExAC
gnomAD
CA181505040
rs369624843
462 S>Y No ClinGen
ESP
TOPMed
CA4816847
rs770553248
467 T>I No ClinGen
ExAC
gnomAD
CA4816848
rs755058858
468 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA371759059
rs1245156962
469 G>D No ClinGen
gnomAD
CA4816850
rs748159287
470 V>F No ClinGen
ExAC
TOPMed
gnomAD
CA371759062
rs748159287
470 V>I No ClinGen
ExAC
TOPMed
gnomAD
rs374099167
CA4816852
472 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs777723258
CA4816853
472 K>N No ClinGen
ExAC
gnomAD
rs1422997267
CA371759082
473 K>T No ClinGen
gnomAD

1 associated diseases with P48651

[MIM: 151050]: Lenz-Majewski hyperostotic dwarfism (LMHD)

A syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. LMHD is characterized by the combination of sclerosing bone dysplasia, intellectual disability and distinct craniofacial, dental, cutaneous and distal limb anomalies. The progressive generalized hyperostosis associated with this syndrome affects the cranium, the vertebrae and the diaphyses of tubular bones, leading to severe growth restriction. {ECO:0000269|PubMed:24241535}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A syndrome of intellectual disability and multiple congenital anomalies that features generalized craniotubular hyperostosis. LMHD is characterized by the combination of sclerosing bone dysplasia, intellectual disability and distinct craniofacial, dental, cutaneous and distal limb anomalies. The progressive generalized hyperostosis associated with this syndrome affects the cranium, the vertebrae and the diaphyses of tubular bones, leading to severe growth restriction. {ECO:0000269|PubMed:24241535}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for P48651

Type Name Position InterPro Accession
conserved_site Squalene/phytoene synthase, conserved site 239 - 254 IPR019845-1
conserved_site Squalene/phytoene synthase, conserved site 275 - 300 IPR019845-2
domain Trans-isoprenyl diphosphate synthases, head-to-head 122 - 389 IPR033904

Functions

Description
EC Number 2.7.8.29 Transferases for other substituted phosphate groups
Subcellular Localization
  • Endoplasmic reticulum membrane ; Multi-pass membrane protein
  • Highly enriched in the mitochondria-associated membrane (MAM)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
membrane A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.

3 GO annotations of molecular function

Name Definition
L-serine-phosphatidylcholine phosphatidyltransferase activity Catalysis of the reaction: a 1,2-diacyl-sn-glycero-3-phosphocholine + L-serine = 1,2-diacyl-sn-glycero-3-phospho-L-serine + choline.
L-serine-phosphatidylethanolamine phosphatidyltransferase activity Catalysis of the reaction: L-1-phosphatidylethanolamine + L-serine <=> L-1-phosphatidylserine + ethanolamine.
transferase activity Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.

1 GO annotations of biological process

Name Definition
phosphatidylserine biosynthetic process The chemical reactions and pathways resulting in the formation of phosphatidylserines, any of a class of glycerophospholipids in which the phosphatidyl group is esterified to the hydroxyl group of L-serine.

11 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q2KHY9 PTDSS1 Phosphatidylserine synthase 1 Bos taurus (Bovine) PR
E1BYA3 PTDSS1 Phosphatidylserine synthase 2 Gallus gallus (Chicken) PR
Q5ZM65 PTDSS1 Phosphatidylserine synthase 1 Gallus gallus (Chicken) PR
Q9Z1X2 Ptdss2 Phosphatidylserine synthase 2 Mus musculus (Mouse) PR
Q99LH2 Ptdss1 Phosphatidylserine synthase 1 Mus musculus (Mouse) PR
Q5PQL5 Ptdss1 Phosphatidylserine synthase 1 Rattus norvegicus (Rat) PR
Q6I628 PSS2 CDP-diacylglycerol--serine O-phosphatidyltransferase 2 Oryza sativa subsp japonica (Rice) PR
Q5N8Q3 PSS3 CDP-diacylglycerol--serine O-phosphatidyltransferase 3 Oryza sativa subsp japonica (Rice) PR
F4HXY7 PSS1 CDP-diacylglycerol--serine O-phosphatidyltransferase 1 Arabidopsis thaliana (Mouse-ear cress) PR
Q08D11 ptdss2 Phosphatidylserine synthase 2 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
E7EY42 ptdss2 Phosphatidylserine synthase 2 Danio rerio (Zebrafish) (Brachydanio rerio) PR
10 20 30 40 50 60
MASCVGSRTL SKDDVNYKMH FRMINEQQVE DITIDFFYRP HTITLLSFTI VSLMYFAFTR
70 80 90 100 110 120
DDSVPEDNIW RGILSVIFFF LIISVLAFPN GPFTRPHPAL WRMVFGLSVL YFLFLVFLLF
130 140 150 160 170 180
LNFEQVKSLM YWLDPNLRYA TREADVMEYA VNCHVITWER IISHFDIFAF GHFWGWAMKA
190 200 210 220 230 240
LLIRSYGLCW TISITWELTE LFFMHLLPNF AECWWDQVIL DILLCNGGGI WLGMVVCRFL
250 260 270 280 290 300
EMRTYHWASF KDIHTTTGKI KRAVLQFTPA SWTYVRWFDP KSSFQRVAGV YLFMIIWQLT
310 320 330 340 350 360
ELNTFFLKHI FVFQASHPLS WGRILFIGGI TAPTVRQYYA YLTDTQCKRV GTQCWVFGVI
370 380 390 400 410 420
GFLEAIVCIK FGQDLFSKTQ ILYVVLWLLC VAFTTFLCLY GMIWYAEHYG HREKTYSECE
430 440 450 460 470
DGTYSPEISW HHRKGTKGSE DSPPKHAGNN ESHSSRRRNR HSKSKVTNGV GKK